人工智能图像融合系统对比标准治疗引导血管内主动脉瘤修复(ARIA)的多中心随机对照试验统计分析计划
ARIA试验为III期多中心开放标签两臂平行组随机对照外科试验,计划招募340例腹主动脉或胸腹主动脉瘤患者,随机接受标准血管内修复或Cydar-EV辅助的血管内修复,主要结局为基线时手术时长,并制定缺失数据、协变量调整及敏感性分析的统计方法。
要点
- ARIA为III期多中心开放标签两臂平行组随机对照试验,计划招募340例腹主动脉或胸腹主动脉瘤患者。
- 主要结局为基线时手术时长,次要结局涵盖技术有效性、患者结局、手术效率与成本效果。
- 统计分析计划包括缺失数据处理、调整分析协变量及敏感性分析方法。
核心结论
- 本文描述ARIA试验的统计分析计划,旨在评估Cydar-EV辅助血管内动脉瘤修复能否缩短手术时长并提升手术精度、患者结局与成本效果。
研究设计与样本
- ARIA为III期多中心开放标签两臂平行组随机对照外科试验,计划招募340例诊断为腹主动脉或胸腹主动脉瘤的患者。
- 参与者随机接受标准血管内修复或Cydar-EV辅助规划与手术引导的血管内修复。
- 主要与次要结局在基线、4至12周和52周评估。
- 主要结局指标为基线时手术时长。
- 试验于2021年12月3日在ISRCTN注册,注册号ISRCTN13832085。
主要发现
- 本文为统计分析计划,未报告试验结果。
关键数值与推荐
- 主要结局为基线时手术时长。
- 次要结局包括技术有效性、患者结局、手术效率和成本效果指标。
- 患者结局数据按实际接受的治疗分析,而不论初始分配。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Aortic aneurysms, a significant cause of mortality, particularly in individuals aged 55 years and older, have witnessed a transformative shift in treatment strategies with the advent of endovascular surgery. Cydar-EV is an innovative image fusion technology that can augment preoperative planning and surgical guidance of endovascular aneurysm repair (EVAR). The ARIA trial aims to evaluate the efficacy of using Cydar-EV with EVAR procedures to reduce operating time while enhancing procedural precision, patient outcomes, and cost-effectiveness. This paper describes the statistical analysis plan for the study. METHODS/DESIGN: The ARIA trial, a phase III, multi-centre, open-label, two-armed, parallel groups randomised controlled surgical trial, seeks to recruit 340 patients diagnosed with abdominal or thoraco-abdominal aortic aneurysms. Participants are randomly assigned to receive either standard endovascular repair or an endovascular repair assisted by Cydar-EV for planning and surgical guidance. Primary and secondary outcomes are assessed at baseline, 4-12 weeks, and 52 weeks. The primary outcome measure is procedure duration at baseline, while additional secondary outcomes are recorded at various time points and include indicators for technical effectiveness, patient outcomes, procedure efficiency, and cost-effectiveness. We plan to analyse the patient outcome data according to the treatment they received regardless of initial allocation. The statistical analysis plan outlines methods for handling missing data, covariates for adjusted analyses, and planned sensitivity analyses to ensure robust evaluation of treatment effects. TRIAL REGISTRATION: The trial was registered with the ISRCTN register on 03/12/2021, number ISRCTN13832085.
引用
- Wafa HA, Budge J, Carrell T, et al. Statistical analysis plan for the ARtificially Intelligent image fusion system versus standard treatment to guide endovascular Aortic aneurysm repair (ARIA): a multi-centre randomised controlled trial. Trials. 2025. PMID: 40307841. doi:10.1186/s13063-025-08770-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。